Silexion Therapeutics Corp

Healthcare · Biotechnology · Israel

Last price 0.1452 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 807.35K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.